International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
Emerg Infect Dis. 2010 Nov;16(11):1718-23. doi: 10.3201/eid1611.090934.
In 1999, a review of the literature for 1966-1997 suggested that ≈1.1 million persons die annually of shigellosis, including ≈880,000 in Asia. Our recent review of the literature for 1990-2009 indicates that ≈125 million shigellosis cases occur annually in Asia, of which ≈14,000 are fatal. This estimate for illnesses is similar to the earlier estimate, but the number of deaths is 98% lower; that is, the lower estimate of deaths is associated with markedly reduced case-fatality rates rather than fewer cases. Shigella spp.-related deaths decreased substantially during a period without Shigella spp.-specific interventions. We speculate that nonspecific interventions, e.g., measles vaccination, vitamin A supplementation, and improved nutrition, may have led to the reduced number of shigellosis-related deaths.
1999 年,对 1966 年至 1997 年文献的回顾表明,每年约有 110 万人死于志贺氏菌病,其中亚洲约有 88 万人。我们最近对 1990 年至 2009 年文献的回顾表明,亚洲每年约有 1.25 亿例志贺氏菌病,其中约有 1.4 万人死亡。这一疾病估计与早期估计相似,但死亡人数低 98%;也就是说,死亡人数的低估计与病死率的显著降低有关,而不是病例数的减少。在没有志贺氏菌特异性干预的情况下,志贺氏菌相关死亡人数大幅下降。我们推测,非特异性干预措施,如麻疹疫苗接种、维生素 A 补充和改善营养,可能导致志贺氏菌病相关死亡人数减少。